Dexmedetomidine for Postoperative Sedation in Patients Undergoing Repair of Thoracoabdominal Aortic Aneurysms
Status:
Terminated
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to test the hypothesis that time on the ventilator and
ICU length of stay will be shorter in TAA patients given postoperative sedation with
dexmedetomidine compared to those given standard sedation. Secondary endpoints are:
requirement for sedatives vasoactive drugs incidence of postoperative delirium and cost
analysis.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
Hospira, Inc. Hospira, now a wholly owned subsidiary of Pfizer